BioHealth News Archive

Ron Kurz, Sr. Director & GM at Canon Virginia, Inc., visits the BioTalk Podcast

Ron Kurz, Sr. Director & GM at Canon Virginia, Inc., visits the BioTalk Podcast

Ron Kurz, Sr. Director & GM at Canon Virginia, Inc., joins BioTalk to discuss his career, growth opportunities, and Canon’s role in the BioHealth…

Read More
CareDx Leads the Way in Xenotransplant Organ Surveillance

CareDx Leads the Way in Xenotransplant Organ Surveillance

SOUTH SAN FRANCISCO, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and…

Read More
Johns Hopkins Tops List Of Leading Universities For NIH Funding In 2021

Johns Hopkins Tops List Of Leading Universities For NIH Funding In 2021

Johns Hopkins University led all U.S. institutions in total National Institutes of Health (NIH) funding for federal fiscal year 2021, with more than $820…

Read More
Emergent underway with $100M in manufacturing upgrades as it gears up for ‘post-pandemic work’ | FiercePharma

Emergent underway with $100M in manufacturing upgrades as it gears up for ‘post-pandemic work’ | FiercePharma

After struggling through COVID-19 vaccine production woes in 2021, Emergent BioSolutions has another surprise for its investors in early 2022.  Last month, Emergent projected revenues…

Read More
BHI’s next EIR Feedback Day is March 16th

BHI’s next EIR Feedback Day is March 16th

These free 1:1 virtual sessions are an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices. If you’re…

Read More
Opportunity: Entrepreneur-In-Residence Role with BioHealth Innovation, Inc. and NIH

Opportunity: Entrepreneur-In-Residence Role with BioHealth Innovation, Inc. and NIH

POSITION DESCRIPTION – Entrepreneur-In-Residence EIRs will work in collaboration with SEED to mentor innovators and provide guidance to help them de-risk the technical and…

Read More
COVID Vaccines Demonstrated the Potential of mRNA Technology but Common Approaches for Managing Quality are Needed

COVID Vaccines Demonstrated the Potential of mRNA Technology but Common Approaches for Managing Quality are Needed

USP Developing mRNA Quality Guidelines to help companies and regulators bring innovative medicines to market faster   Rockville, Md., February 23, 2022 – U.S.…

Read More
The 2022 Women’s Venture Competition is open for applications until February 28, 2022, 11:59 PM Eastern Time

The 2022 Women’s Venture Competition is open for applications until February 28, 2022, 11:59 PM Eastern Time

The AIM-HI Women’s Venture Competition, in its third year, is open for women entrepreneurs! The program provides early-stage funding, coaching, and networking opportunities to…

Read More
Maryland Tech Council CEO Marty Rosendale joins Rich Bendis on BioTalk

Maryland Tech Council CEO Marty Rosendale joins Rich Bendis on BioTalk

Marty Rosendale, Chief Executive Officer of the Maryland Tech Council, joins BioTalk to discuss MTCs Programs, Accessing Capital, and Goals for 2022 Listen now…

Read More
BHI’s next EIR Feedback Day is March 16th

BHI’s next EIR Feedback Day is March 16th

These free 1:1 virtual sessions are an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices. If you’re…

Read More
Even old foes can learn sweet new tricks: Cell Host & Microbe

Even old foes can learn sweet new tricks: Cell Host & Microbe

In this issue of Cell Host and Microbe, Haslwanter et al., 2022 present a comprehensive investigation into the molecular and functional basis of 17D vaccine…

Read More
In biopharma VC world, what does it mean to take a ‘leap’? For Leaps by Bayer, it’s ‘fewer, but maybe bigger bets’ | Fierce Biotech

In biopharma VC world, what does it mean to take a ‘leap’? For Leaps by Bayer, it’s ‘fewer, but maybe bigger bets’ | Fierce Biotech

Sparking innovation at a Big Pharma with a 150-year history can be difficult, so sometimes it takes some outside perspective to get the ball…

Read More
CEO Exclusive: Healthworx’s Ricardo Johnson on Venture Investment and Tech Decision-Making | HealthLeaders Media

CEO Exclusive: Healthworx’s Ricardo Johnson on Venture Investment and Tech Decision-Making | HealthLeaders Media

This week, HealthLeaders speaks with Ricardo Johnson, CEO of Healthworx—the innovation and venture capital (VC) arm of CareFirst BlueCross BlueShield. Johnson details the plan's…

Read More

Montgomery County streamlines zoning to bolster increasingly competitive biotech sector – Washington Business Journal

In a bid to keep and grow its flagship biohealth sector, Montgomery County is dramatically streamlining its regulatory review process for industry players who…

Read More
Privia Health Leverages Amalgam Rx’s EHR-Integrated Solutions to Personalize Care | Business Wire

Privia Health Leverages Amalgam Rx’s EHR-Integrated Solutions to Personalize Care | Business Wire

WILMINGTON, Del.--(BUSINESS WIRE)--Amalgam Rx, Inc., a leader in connecting healthcare providers, payers, and life sciences companies through a SaaS-enabled digital marketplace and product platform,…

Read More